News

March 2023

• 3/21 - Factors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research

• 3/15 - Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

• 3/9 - IBJ Honors Regenstrief research scientist with Heath Care Hero Award 

• 3/7 - LOINC 2.74 Release Webinar scheduled for spring 2023

• 3/6 - LOINC continues facilitating health data interoperability with biannual issuance of new concepts

February 2023

• 2/27 - Study identifies four distinct pain trajectories in nursing home residents

• 2/22 - Study one of first to compare pain relief options for chronic low back pain patients already on opioids

• 2/8 - Regenstrief-led study shows enhanced spiritual care improves well-being of ICU surrogate decision-makers

• 2/8 - JAMA study finds electronic health records do not accurately identify common barriers to health

• 2/6 - Patzer new Regenstrief Institute president, CEO

• 2/2 - Dementia complicates cancer care, increasing risk of poorer clinical outcomes and patient experience

January 2023

• 1/26 - Blood sugar monitoring devices pose wearability and use problems for older adults with diabetes and caregivers

• 1/24 - Expanding the national dialogue on healthcare to include the intersection of structural racism and ageism

• 1/18 - Regenstrief Institute research scientists study online colorectal cancer risk calculators

• 1/17 - Novel framework provides ‘measuring stick’ for assessing patient matching tools

• 1/12 - Benzodiazepine tightrope: Experts advocate provider and patient education, surveillance vs. strict governmental regulation

• 1/11 - Gifts from Walther, Regenstrief foundations create cancer informatics chair at IU Simon Comprehensive Cancer Center

• 1/4 - Study surveys landscape of apps built on increasingly popular FHIR® standard

December 2022

• 12/21 - Digital Detection of Dementia: Using AI to identify undiagnosed dementia

• 12/19 - Real-world data study confirms bivalent mRNA booster vaccines associated with greater short-term protection against symptomatic COVID-19 infections in adults

• 12/15 - Clement McDonald, M.D., honored for his pioneering work in medical informatics at Regenstrief Institute to improve health in Indiana and around the world

• 12/15 - Regenstrief research scientist receives Beeson Emerging Leaders Career Development Award

• 12/15 - Large, real-world study finds COVID-19 vaccination more effective than natural immunity in protecting against all causes of death, hospitalization and emergency department visits

• 12/8 - $11M NIH grant will support evaluation of Alzheimer’s screening tool in primary care settings

• 12/7 - National study confirms breakthrough COVID cases are less severe than COVID in unvaccinated adults

• 12/6 - Redesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease

November 2022

• 11/29 - New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

• 11/4 - Regenstrief researcher among 14 fellows to be inducted into American College of Medical Informatics

• 11/3 - NIA deputy director visits IU Center for Aging Research at Regenstrief

• 11/3 - Tailored online personal health record cancer tool increases survivor adherence to national guidelines

October 2022

• 10/29 - 38 countries collaborate to drive change, improve healthcare equity at LOINC Conference in France

• 10/28 - New collaboration agreement between SNOMED International and LOINC® from Regenstrief pivotal step to enhance interoperability, health information exchange around the world

• 10/26 - Multistate study examines mRNA vaccine effectiveness for immunocompromised adults during Omicron BA.4 and BA.5 predominance

• 10/25 - A quarter-century of improving the health and quality of life of older adults

• 10/20 - Regenstrief, IDOH collaborating on flu data and analysis for public health

• 10/13 - Unvaccinated adult cancer patients with COVID seven times more likely to die from any cause than comparable patients without COVID infection

• 10/6 - Large JAMA study reports very low incidence of severe COVID-19 following vaccination and booster

• 10/6 - University, high school summer students experience real-world research at Regenstrief Institute 

• 10/3 - Large U.S. study confirms that mRNA boosters extend COVID-19 protection but wane over time, strongly supporting need for additional boosters

September 2022

• 9/26 - National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

• 9/22 - Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds

• 9/16 - Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

• 9/12 - Treble clef treatment: Music to counter delirium in mechanically ventilated older adults in the ICU

• 9/7 - Regenstrief and IU developing one of first population-based surveillance systems for long COVID to determine prevalence, trends and outcomes

August 2022

• 8/23 - Regenstrief research scientist 1 of 33 NIA small business mentors

• 8/23 - Regenstrief research scientist to lead American Delirium Society for 2023-24 term 

• 8/17 - LOINC® issues new monkeypox, COVID and other concepts; adds Ukrainian translation 

• 8/16 - Research team awarded more than $10 million to improve cognitive recovery of post-operative delirium survivors 

• 8/12 - Regenstrief Institute appoints Nist interim CIO

• 8/5 - OpenHIE to host virtual community meeting over 3 days in September